Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer

MLA

Michael Mints, et al. “Tumour Inflammation Signature and Expression of S100A12 and HLA Class I Improve Survival in HPV-Negative Hypopharyngeal Cancer.” Scientific Reports, vol. 11, no. 1, Jan. 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41598-020-80226-z.

APA

Michael Mints, David Landin, Anders Näsman, Leila Mirzaie, Ramona Gabriela Ursu, Mark Zupancic, Linda Marklund, Tina Dalianis, Eva Munck-Wikland, & Torbjörn Ramqvist. (2021). Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer. Scientific Reports, 11(1), 1–11. https://doi.org/10.1038/s41598-020-80226-z

Chicago

Michael Mints, David Landin, Anders Näsman, Leila Mirzaie, Ramona Gabriela Ursu, Mark Zupancic, Linda Marklund, Tina Dalianis, Eva Munck-Wikland, and Torbjörn Ramqvist. 2021. “Tumour Inflammation Signature and Expression of S100A12 and HLA Class I Improve Survival in HPV-Negative Hypopharyngeal Cancer.” Scientific Reports 11 (1): 1–11. doi:10.1038/s41598-020-80226-z.